Acta Oncologica

Papers
(The H4-Index of Acta Oncologica is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark51
Trends in cancer survival in the Nordic countries 1990–2016: the NORDCAN survival studies43
BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis42
Comparing different CT, PET and MRI multi-modality image combinations for deep learning-based head and neck tumor segmentation42
Cancer patients’ preferred and perceived level of involvement in treatment decision-making: an epidemiological study38
Quality of life in patients with cancer during the COVID-19 pandemic – a Danish cross-sectional study (COPICADS)37
Patient-reported outcomes 1 year after oesophageal cancer surgery36
Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data35
The eHealth self-management application ‘Oncokompas’ that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?32
Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy30
Education, income and risk of cancer: results from a Norwegian registry-based study29
Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease28
Decreasing access to cancer diagnosis and treatment during the COVID-19 pandemic in Poland28
Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms27
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab27
Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac25
Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy25
Effects from physical exercise on reduced cancer-related fatigue: a systematic review of systematic reviews and meta-analysis25
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review24
Accelerator-based boron neutron capture therapy facility at the Helsinki University Hospital24
Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer24
Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses23
Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study23
0.10757088661194